Cargando…

Breast Cancer Genetics: Diagnostics and Treatment

Detalles Bibliográficos
Autores principales:	Criscitiello, Carmen, Corti, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498728/ https://www.ncbi.nlm.nih.gov/pubmed/36140761 http://dx.doi.org/10.3390/genes13091593

Ejemplares similares

Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer
por: Corti, C., et al.
Publicado: (2021)

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution
por: Giugliano, Federica, et al.
Publicado: (2023)

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers
por: Fusco, Nicola, et al.
Publicado: (2023)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer
por: Esposito, Angela, et al.
Publicado: (2015)

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Bibliometric analysis of an important diagnostic technique for the treatment of breast cancer
por: Teles, Ramon Handerson Gomes, et al.
Publicado: (2022)

Toward precision medicine in inflammatory breast cancer
por: Viale, Giulia, et al.
Publicado: (2019)

From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer
por: Ki, Chang-Seok
Publicado: (2020)

Immune approaches to the treatment of breast cancer, around the corner?
por: Criscitiello, Carmen, et al.
Publicado: (2014)

Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020)

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective
por: Lambertini, Matteo, et al.
Publicado: (2020)

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
por: Diana, Anna, et al.
Publicado: (2020)

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?
por: Curigliano, Giuseppe, et al.
Publicado: (2013)

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
por: Criscitiello, Carmen, et al.
Publicado: (2010)

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
por: Fusco, Nicola, et al.
Publicado: (2020)

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets
por: Lammers, Philip, et al.
Publicado: (2014)

Genetic Determinants of Breast Cancer Risk in Childhood Cancer Survivors
por: Meier, Magda, et al.
Publicado: (2017)

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
por: Marra, Antonio, et al.
Publicado: (2020)

Antibody–Drug Conjugates for the Treatment of Breast Cancer
por: Corti, Chiara, et al.
Publicado: (2021)

Metastasis: Genetics, Mechanism, and Diagnostic and Therapeutic Strategies
por: Gunduz, Mehmet, et al.
Publicado: (2012)

Diagnostics and Therapeutics in Early Stage Breast Cancer Receiving Neoadjuvant Systemic Therapy
por: Belli, Paolo, et al.
Publicado: (2023)

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
por: Venetis, Konstantinos, et al.
Publicado: (2021)

Cancer diagnostics and treatment: are we ready to implement PPPM?
por: Desiderio, Dominic M.
Publicado: (2010)

Audit in a diagnostic breast imaging service
por: Koch, Hilton
Publicado: (2014)

Best management of locally advanced inoperable breast cancer
por: Curigliano, Giuseppe, et al.
Publicado: (2013)

Editorial for the Special Issue “Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics”
por: Nabieva, Naiba
Publicado: (2023)

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
por: Ascione, Liliana, et al.
Publicado: (2022)

A Molecular, Genetic, and Diagnostic Spotlight on Fanconi Anemia
por: Hays, Laura E., et al.
Publicado: (2012)

Rats: gnawing through the barriers to understanding genetic susceptibility and breast cancer
por: Blackburn, Anneke C
Publicado: (2011)

Molecular Research and Treatment of Breast Cancer
por: Kawiak, Anna
Publicado: (2022)

Repurposing ARBs as treatments for breast cancer
por: George, Amee J., et al.
Publicado: (2017)

Natural cures for breast cancer treatment
por: Shareef, Munazza, et al.
Publicado: (2016)

Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023)

Advances in the Surgical Treatment of Breast Cancer
por: Cheifetz, Rona, et al.
Publicado: (2023)

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
por: Preusser, Matthias, et al.
Publicado: (2018)

Special Issue “Advancement in Breast Diagnostic and Interventional Radiology”
por: Di Grezia, Graziella
Publicado: (2022)

Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
por: Ivanova, Mariia, et al.
Publicado: (2023)

Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning”
por: Tokas, Theodoros
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3hesm816t1rb5gq20bfm6dfdlk